Received May 21, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTPPVHBHPB | DTAP+IPV+HIB+HEPB (VAXELIS) | MSP VACCINE COMPANY | 2 | U8510AA | — |
Administration of VAXILIS PFS twice to a patient within 8 days period; This non-serious spontaneous safety report, with reference number 02962934, was received by partner on 13-MAR-2026 and forwarded on 13-MAR-2026 from a physician and office manager. Due to the nature of the event, the causality between the event 'Administration of VAXILIS PFS twice to a patient within 8 days period' and Vaxelis was not applicable. Further information is expected.
Prophylaxis